X4 Pharmaceuticals Inc.
XFOR | NASDAQ
$3.44
-$0.06 (-1.57%)
Sep 22, 2026, 12:48 PM ET · Market open
Market Data
Market Cap $329.65M
Enterprise Value $122.14M
Beta 0.35
Average Volume 642.91K
Shares Outstanding (Diluted) 126.34M
Shares Change YoY 1604.36%
Institutional Ownership 71.61%
Exchange NASDAQ
ISIN US98420X2027
Price Performance
Price Change 1M -12.5%
Price Change 3M -12.5%
Price Change 6M -14.4%
Price Change YTD -10.0%
Price Change 1Y 3.5%
Price Change 3Y -88.8%
Price Change 5Y -97.9%
1M CAGR (ann.) -24.6%
1Y CAGR (ann.) 8.0%
5Y CAGR (ann.) -53.0%
All-Time CAGR -52.5%
Valuation
PE Ratio -2.92
Forward PE N/A
PEG Ratio -0.01
Forward PEG -0.37
PS Ratio 20.80
Forward PS 28.50
PB Ratio 2.12
P/FCF Ratio -3.94
P/Adj. FCF Ratio -3.57
P/OCF Ratio -5.30
EV/Sales 7.71
EV/EBIT -1.50
EV/EBITDA -1.54
EV/FCF -1.46
Earnings Yield -34.3%
FCF Yield -25.4%
Adj. FCF Yield -28.0%
Financial Health
Net Cash $207.5M
Total Debt $465K
Cash & Short-Term Investments $207.97M
Total Assets $253.06M
Current Ratio 11.30
Quick Ratio 11.02
Debt / Equity Ratio 0.50
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -222.23
Interest Coverage -10.06
Altman Z-Score -1.52
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 81.2%
Operating Profit Margin -554.7%
EBITDA Margin -501.8%
Net Profit Margin -568.8%
FCF Margin -528.4%
Adj. FCF Margin -582.2%
SBC / Revenue 53.8%
SBC Impact (per share) -10.2%
Returns
Return on Assets -35.6%
Return on Equity -63.0%
Return on Invested Capital -37.5%
Return on Capital Employed -37.6%
Return on Tangible Assets -40.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 46.6%
Revenue CAGR 5Y 65.5%
Revenue CAGR 10Y 49.3%
EPS CAGR 3Y -41.6%
EPS CAGR 5Y 73.7%
EPS CAGR 10Y 37.5%
FCF CAGR 3Y 14.1%
FCF CAGR 5Y -5.3%
FCF CAGR 10Y -16.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y 29.4%
Revenue Growth Next 3Y 137.2%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.19
EPS Growth Est (next Q) -72.5%
Revenue Est (next Q) $2.3M
Revenue Growth Est (next Q) 30.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $11.50
Price Target Upside 228.6%
Cash Flow
Operating Cash Flow $-103.34M
Free Cash Flow $-83.74M
Adj. Free Cash Flow $-92.27M
FCF Per Share -$0.66
OCF Per Share -$0.66
OCF/S Ratio -528.4%
Income Statement
Revenue $15.85M
Gross Profit $12.87M
Operating Income $-87.91M
EBITDA $-79.52M
Net Income $-90.14M
EPS (Diluted) -$1.20
Revenue / Employee $352.16K
Profit / Employee $-2M
Employees 45
Add to Watchlist
Select watchlists to add or remove XFOR